{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:19:55Z","timestamp":1787728795329,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007812","name":"University of Washington - Seattle Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yebeh.2025.110583","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T16:47:36Z","timestamp":1751993256000},"page":"110583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6259-7434","authenticated-orcid":false,"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannielle","family":"Zierath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8982-772X","authenticated-orcid":false,"given":"Kevin M.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Steve White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-0553","authenticated-orcid":false,"given":"Melissa","family":"Barker-Haliski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.yebeh.2025.110583_b0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0013-9580.2004.452003.x","article-title":"Therapy for neurobehavioral disorders in epilepsy","volume":"45","author":"Devinsky","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110583_b0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yebeh.2018.03.040","article-title":"Affective and behavioral dysfunction under antiepileptic drugs in epilepsy: Development of a new drug-sensitive screening tool","volume":"83","author":"Mertens","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110583_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110583_b0020","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/epi.13476","article-title":"Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice","volume":"57","author":"Barker-Haliski","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110583_b0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1528-1157.1995.tb01613.x","article-title":"Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs","volume":"36","author":"Honack","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110583_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41398-018-0092-z","article-title":"Amygdala hyper-connectivity in a mouse model of unpredictable early life stress","volume":"8","author":"Johnson","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2025.110583_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113483","article-title":"Information transmission in mPFC-BLA network during exploratory behavior in the open field","volume":"414","author":"Bao","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2025.110583_b0040","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.yebeh.2025.110583_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/jpet.119.257261","article-title":"Repeated intraperitoneal administration of low-concentration methylcellulose leads to systemic histologic lesions without loss of preclinical phenotype","volume":"371","author":"Meeker","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2025.110583_b0050","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/epi.16955","article-title":"Development of an antiepileptogenesis drug screening platform: effects of everolimus and phenobarbital","volume":"62","author":"Barker-Haliski","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110583_b0055","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s11064-017-2227-7","article-title":"Validation of a preclinical drug screening platform for pharmacoresistant epilepsy","volume":"42","author":"Barker-Haliski","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.yebeh.2025.110583_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2025.110583_b0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/epi.17433","article-title":"Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models","volume":"64","author":"Loscher","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110583_b0070","article-title":"Effect of environmental concentration of carbamazepine on the behaviour and gene expression of laboratory rats","volume":"13","author":"Santariova","year":"2023","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.yebeh.2025.110583_b0075","first-page":"127","article-title":"Effect of antiepileptic drugs valproic acid, carbamazepine and ethosuccimide on exploratory behaviour in mice","volume":"29","author":"Rao","year":"1991","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.yebeh.2025.110583_b0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0091-3057(95)02050-0","article-title":"Effects of four antiepileptic drugs on sleep and waking in the rat under both light and dark phases","volume":"53","author":"Bertorelli","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2025.110583_b0085","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1176\/ajp.143.11.1486","article-title":"Sedative or antimanic effects of carbamazepine and treatment of behavioral dyscontrol","volume":"143","author":"Greenberg","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2025.110583_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.593050","article-title":"A potential mechanism of sodium channel mediating the general anesthesia induced by propofol","volume":"14","author":"Xiao","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2025.110583_b0095","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/epi.16525","article-title":"Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study","volume":"61","author":"Sperling","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110583_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13318-023-00862-4","article-title":"Distribution, metabolism, and excretion of cenobamate in adult, fetal, neonatal, and lactating rats","volume":"49","author":"Palamanda","year":"2024","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.yebeh.2025.110583_b0105","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200133","article-title":"Cenobamate in generalized epilepsy and combined generalized and focal epilepsy","volume":"13","author":"Agashe","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.yebeh.2025.110583_b0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/1871527321666220113110044","article-title":"Cenobamate: a review of its pharmacological properties, clinical efficacy and tolerability profile in the treatment of epilepsy","volume":"22","author":"Barbieri","year":"2023","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.yebeh.2025.110583_b0115","series-title":"How synthetic drugs work","first-page":"161","article-title":"7 - Mechanism of action of sedatives, hypnotics, and antianxiety drugs","author":"Nisar","year":"2023"},{"key":"10.1016\/j.yebeh.2025.110583_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.12483","article-title":"Anxiolytic and sedative effects of sodium valproate with different experimental paradigms in male and female rats","author":"de Los Angeles Cintado","year":"2024","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.yebeh.2025.110583_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.yebeh.2025.110583_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107849","article-title":"Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain","volume":"163","author":"Andres-Mach","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2025.110583_b0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2016.09.057","article-title":"A new SV2A ligand for epilepsy","volume":"167","author":"Rogawski","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.yebeh.2025.110583_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108917","article-title":"The differential effect of levetiracetam on memory and anxiety in rats","volume":"136","author":"Zwierzynska","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110583_b0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pbb.2010.05.020","article-title":"Levetiracetam-mediated emotional behavior in heterozygous rolling Nagoya Ca(V)2.1 channel mutant mice","volume":"96","author":"Takahashi","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2025.110583_b0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/schbul\/sbac106","article-title":"Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats","volume":"49","author":"Cavichioli","year":"2023","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.yebeh.2025.110583_b0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2025.110583_b0160","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00011-023-01700-8","article-title":"Neuroinflammatory mediators in acquired epilepsy: an update","volume":"72","author":"Chen","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.yebeh.2025.110583_b0165","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12035-023-03583-6","article-title":"Clinical correlation of altered molecular signatures in epileptic human hippocampus and amygdala","volume":"61","author":"Modarres Mousavi","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2025.110583_b0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.yebeh.2025.110583_b0175","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/epi.16624","article-title":"Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice","volume":"61","author":"Koneval","year":"2020","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:14:04Z","timestamp":1778616844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"alternative-id":["S1525505025003233"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110583","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110583"}}